AssetMark Inc’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

AssetMark Inc’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-24	Closed	-$1K	–	1527
2020 Q3	$1K	Buy	24 +1	+4%	+$41	﹤0.01%	1302
2020 Q2	$1K	Buy	+23	New	+$732	﹤0.01%	1238
2018 Q1	–	Sell	-24	Closed	–	–	2169
2017 Q4	$0	Buy	+24	New	+$324	﹤0.01%	2228
2017 Q1	–	Sell	-7	Closed	–	–	1505
2016 Q4	$0	Buy	+7	New	+$92	﹤0.01%	1433
2015 Q1	–	Sell	-300	Closed	-$4K	–	514
2014 Q4	$4K	Buy	+300	New	+$3.43K	﹤0.01%	458

AssetMark Inc's MNTA Position: Q4 2020 in Review

AssetMark Inc sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 24 shares — an estimated $1K sold.

AssetMark Inc first reported a position in MNTA in Q4 2014 and held it in 5 quarters. The position peaked at $4K in Q4 2014. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

AssetMark Inc reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
AssetMark Inc sold 24 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1K.
AssetMark Inc first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2014 and held it in 5 quarters.
AssetMark Inc's Momenta Pharmaceuticals, Inc. position peaked at $4K in Q4 2014.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on AssetMark Inc's 13F filing for Q4 2020, filed 10 Feb 2021.